Zacks: Analysts Expect Avenue Therapeutics Inc (NASDAQ:ATXI) to Post -$0.29 EPS

Retrieved on: 2019-12-18 07:15:00

Tags for this article:

IAC

Financial ratios

Avenue Therapeutics Inc.

Click the tags to see associated articles and topics

Zacks: Analysts Expect Avenue Therapeutics Inc (NASDAQ:ATXI) to Post -$0.29 EPS. View article details on hiswai:

Excerpt

<div><b>BlackRock Inc</b>. grew its stake in shares of Avenue Therapeutics by 135.7% during the second quarter. <b>BlackRock Inc</b>. now owns 39,933 shares of the ...</div>

Article found on:

View Original Article